Key Finding
Acupuncture combined with Chinese herbal medicine demonstrated moderate-certainty evidence for improving sleep quality in menopausal women, though most complementary therapies showed only low to very low certainty evidence overall.
Researchers conducted a comprehensive review of complementary therapies for menopause symptoms to help update international treatment guidelines. They searched six medical databases and analyzed 158 studies, including clinical trials and systematic reviews, examining various complementary approaches including acupuncture, Chinese herbal medicine, vitamin supplements, and mind-body therapies.
The review found that while many complementary therapies showed promise for managing menopause symptoms like hot flashes, sleep problems, and overall menopausal discomfort, most studies were of low quality. However, some therapies had stronger evidence: black cohosh showed moderate-quality evidence for reducing hot flashes and improving overall menopause scores, Chinese herbal medicine demonstrated moderate evidence for improving menopause symptoms, sleep quality, and blood pressure, and acupuncture combined with Chinese herbal medicine showed moderate evidence for better sleep. Vitamin D had high-quality evidence supporting its safety and moderate evidence for reducing fracture risk.
Most complementary therapies appeared safe with few serious side effects reported. The researchers concluded that vitamin D, black cohosh, Chinese herbal medicine, and acupuncture combined with herbal medicine may help certain menopause symptoms, though the overall evidence remains limited.
What this means for women considering acupuncture: While acupuncture showed promising results, especially when combined with Chinese herbal medicine for sleep problems, more high-quality research is needed to fully understand its effectiveness for various menopause symptoms. The safety profile appears favorable with minimal side effects reported. If you're considering acupuncture for menopause symptoms, seek care from a licensed acupuncturist with experience treating menopausal women.
This systematic review examined complementary therapies for menopause management to inform International Menopause Society recommendations. Researchers searched six databases (January 2022-December 2024), identifying 158 studies from 3,187 citations: one overview, 36 meta-analyses, seven systematic reviews, and 114 RCTs. Quality assessment utilized Cochrane RoB2, AMSTAR 2, and GRADE criteria.
Findings revealed predominantly low to very low certainty evidence for most interventions including acupuncture, Chinese herbal medicine (CHM), herbs, nutrients, and mind-body therapies. High-certainty evidence supported vitamin D safety. Moderate-certainty evidence demonstrated efficacy for black cohosh (vasomotor/menopausal symptoms), CHM (menopausal symptoms, sleep, blood pressure), acupuncture plus CHM (sleep), and vitamin D (fracture risk reduction).
Clinical takeaway: While acupuncture combined with CHM shows moderate-certainty evidence for sleep improvement, and various complementary modalities demonstrate safety and potential benefit, practitioners should counsel patients that evidence quality remains limited. Acupuncture may be considered as adjunctive therapy for menopausal symptoms, particularly sleep disturbances when combined with CHM, though more rigorous research is needed to establish definitive treatment protocols.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.